Search
Search Results
##search.searchResults.foundPlural##
-
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2117PDF: 1688HTML: 375 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3990PDF: 1049HTML: 3589Untitled: 177Cneo. Fig.1: 113Untitled: 104Untitled: 126Untitled: 131 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3309PDF: 1465HTML: 3998 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2486PDF: 837HTML: 8819Efremov 1: 226Efremov 2: 187 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2797PDF: 1005HTML: 5519 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3051PDF: 873HTML: 7162Kost Fig1: 182Kost Fig 2: 177Kost Fig3: 174Kost Fig 4: 189Kost Fig5: 184Kost fig 6: 173 -
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1652PDF: 1173HTML: 200 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2942PDF: 889HTML: 1870 -
BLINATUMOMAB IN THE THERAPY OF ACUTE B-LYMPHOID LEUKEMIA BLINATUMOMAB and ALL
1620PDF: 1092HTML: 116 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3578PDF: 881HTML: 6710 -
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1362PDF: 754HTML: 942 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1370HTML: 391PDF: 818 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1331PDF: 822HTML: 129 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3760PDF: 1652HTML: 11579Figures Haase: 198 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1778PDF: 965HTML: 141 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
473PDF: 243HTML: 77 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1657PDF: 746HTML: 243 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1227PDF: 756HTML: 313 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1983PDF: 1123HTML: 620 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2767PDF: 1807HTML: 3665Pellagatti Fig 1: 214Pellagatti Fig. 2: 209 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1381PDF: 816HTML: 3121 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1518PDF: 533HTML: 269 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1179PDF: 751HTML: 1347Figure 1: 186Figure 2: 188 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2544PDF: 1130HTML: 139 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
946PDF: 1204HTML: 108







